Investment in microbiome research, specifically in the gut, is expected to increase substantially over the next 10 years – alongside the launch of several new firms dedicated to this science – as interest in bacterial treatments grows with the accumulation of data from active players. Venture capital group Seventure Partners has already launched a new €160m fund, HealthForLife Capital, focusing solely on microbiome investments, to ride this wave of enthusiasm.
In 2016, the global microbiome market was estimated to be worth around $184m, and is expected to grow at a...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?